Related references
Note: Only part of the references are listed.A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers
Kristen K. Pierce et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Vaccines for tick-borne diseases and cost-effectiveness of vaccination: a public health challenge to reduce the diseases' burden
Renata Smit et al.
EXPERT REVIEW OF VACCINES (2016)
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations
Neal Van Hoeven et al.
PLOS ONE (2016)
The challenge of West Nile virus in Europe: knowledge gaps and research priorities
A. Rizzoli et al.
EUROSURVEILLANCE (2015)
Usutu Virus: An Emerging Flavivirus in Europe
Usama Ashraf et al.
VIRUSES-BASEL (2015)
Current trends in West Nile virus vaccine development
Ian J. Amanna et al.
EXPERT REVIEW OF VACCINES (2014)
Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review
Sandro Zambito Marsala et al.
NEUROLOGICAL SCIENCES (2014)
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available
Tomohiro Ishikawa et al.
VACCINE (2014)
Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010
L. R. Petersen et al.
EPIDEMIOLOGY AND INFECTION (2013)
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers
Anna P. Durbin et al.
VACCINE (2013)
Vaccines in Development against West Nile Virus
Samantha Brandler et al.
VIRUSES-BASEL (2013)
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines
Daniela Amicizia et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Flaviviruses in Europe: Complex Circulation Patterns and Their Consequences for the Diagnosis and Control of West Nile Disease
Cecile Beck et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2013)
Vaccination and Tick-borne Encephalitis, Central Europe
Franz X. Heinz et al.
EMERGING INFECTIOUS DISEASES (2013)
Vaccines and vaccination against tick-borne encephalitis
Herwig Kollaritsch et al.
EXPERT REVIEW OF VACCINES (2012)
West Nile virus cluster analysis and vertical transmission in Culex pipiens complex mosquitoes in Sacramento and Yolo Counties, California, 2011
Ethan Fechter-Leggett et al.
JOURNAL OF VECTOR ECOLOGY (2012)
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age
Gustavo H. Dayan et al.
VACCINE (2012)
Recent progress in West Nile virus diagnosis and vaccination
Marina De Filette et al.
VETERINARY RESEARCH (2012)
The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere
K. O. Murray et al.
EPIDEMIOLOGY AND INFECTION (2011)
Flavivirus-induced antibody cross-reactivity
Karen L. Mansfield et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Rex Biedenbender et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai et al.
SCIENCE (2010)
Tick-borne encephalitis: Pathogenesis and clinical implications
Daniel Ruzek et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2010)
West Nile Virus Infections
Kymberly A. Gyure
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development
Theodore C. Pierson et al.
CELL HOST & MICROBE (2008)
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial
Julie E. Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Detection of West Nile virus lineages 1 and 2 by real-time PCR
Sonja Linke et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Development and persistence of west nile virus-specific immunoglobulin m (IgM), IgA, and IgG in viremic blood donors
HE Prince et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies
WR Hogrefe et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Role of CD8+ T cells in control of West Nile virus infection
B Shrestha et al.
JOURNAL OF VIROLOGY (2004)
Tick-borne virus diseases of human interest in Europe
RN Charrel et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
CD8(+) T cells mediate recovery and immunopathology in west nile virus encephalitis
Y Wang et al.
JOURNAL OF VIROLOGY (2003)
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey
F Mostashari et al.
LANCET (2001)
Share Paper
